Allantoin in human urine quantified by ultra-performance liquid chromatography-tandem mass spectrometry

Analytical Biochemistry

Volumn 402, Issue 2, 2010, Pages 191-193

  Tolun, Adviye A ^a   Zhang, Haoyue ^a   Il'yasova, Dora ^a   Sztáray, Judit ^a   Young, Sarah P ^a   Millington, David S ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLANTOIN; DRUG PRODUCTS; FREE RADICALS; MASS SPECTROMETRY; ORGANIC ACIDS;

CLINICAL STUDY; HIGH THROUGHPUT; INDUCED OXIDATIONS; LIMIT OF DETECTION; POTENT ANTIOXIDANTS; SAMPLE PREPARATION; SINGLET OXYGEN; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

LIQUID CHROMATOGRAPHY;

ALLANTOIN;

ACCURACY; ANALYTIC METHOD; ARTICLE; CHEMICAL STRUCTURE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROCESS OPTIMIZATION; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; URINALYSIS; VALIDATION STUDY;

EID: 77953083232     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2010.03.033     Document Type: Article

References (25)

1. Halliwell B., Gutteridge J.M.C. Free Radicals in Biology and Medicine 2007, Oxford University Press, New York.
2. Halliwell B., Whiteman M. Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?. Br. J. Pharmacol. 2004, 142:231-255.
3. Halliwell B. The wanderings of a free radical. Free Radic. Biol. Med. 2009, 46:531-542.
4. Ames B.N., Cathcart R., Schwiers E., Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc. Natl. Acad. Sci. USA 1981, 78:6858-6862.
5. Grootveld M., Halliwell B. Measurement of allantoin and uric acid in human body fluids: a potential index of free-radical reactions in vivo?. Biochem. J. 1987, 243:803-808.
6. Kaur H., Halliwell B. Action of biologically-relevant oxidizing species upon uric acid: identification of uric acid oxidation products. Chem. Biol. Interact. 1990, 73:235-247.
7. Berthemy A., Newton J., Wu D., Buhrman D. Quantitative determination of an extremely polar compound allantoin in human urine by LC-MS/MS based on the separation on a polymeric amino column. J. Pharm. Biomed. Anal. 1999, 19:429-434.
8. Doehner W., Schoene N., Rauchhaus M., Leyva-Leon F., Pavitt D.V., Reaveley D.A., Schuler G., Coats A.J., Anker S.D., Hambrecht R. Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies. Circulation 2002, 105:2619-2624.
9. Kand'ar R., Zakova P., Muzakova V. Monitoring of antioxidant properties of uric acid in humans for a consideration measuring of levels of allantoin in plasma by liquid chromatography. Clin. Chim. Acta 2006, 365:249-256.
10. Pavitt D.V., de Fonseka S., Al-Khalaf N., Cam J.M., Reaveley D.A. Assay of serum allantoin in humans by gas chromatography-mass spectrometry. Clin. Chim. Acta 2002, 318:63-70.
11. Benzie I.F., Chung W., Tomlinson B. Simultaneous measurement of allantoin and urate in plasma: analytical evaluation and potential clinical application in oxidant:antioxidant balance studies. Clin. Chem. 1999, 45:901-904.
12. Lux O., Naidoo D., Salonikas C. Improved HPLC method for the simultaneous measurement of allantoin and uric acid in plasma. Ann. Clin. Biochem. 1992, 29:674-675.
13. Ma S.W., Tomlinson B., Benzie I.F. A study of the effect of oral glucose loading on plasma oxidant:antioxidant balance in normal subjects. Eur. J. Nutr. 2005, 44:250-254.
14. Yardim-Akaydin S., Sepici A., Ozkan Y., Simsek B., Sepici V. Evaluation of allantoin levels as a new marker of oxidative stress in Behcet's disease. Scand. J. Rheumatol. 2006, 35:61-64.
15. Yardim-Akaydin S., Sepici A., Ozkan Y., Torun M., Simsek B., Sepici V. Oxidation of uric acid in rheumatoid arthritis: is allantoin a marker of oxidative stress?. Free Radic. Res. 2004, 38:623-628.
16. Ogihara T., Kim H.S., Hirano K., Imanishi M., Ogihara H., Tamai H., Okamoto R., Mino M. Oxidation products of uric acid and ascorbic acid in preterm infants with chronic lung disease. Biol. Neonate 1998, 73:24-33.
17. Ogihara T., Okamoto R., Kim H.S., Nagai A., Morinobu T., Moji H., Kamegai H., Hirano K., Ogihara H., Tamai H., Mino M. New evidence for the involvement of oxygen radicals in triggering neonatal chronic lung disease. Pediatr. Res. 1996, 39:117-119.
18. Ferenci P. Pathophysiology and clinical features of Wilson disease. Metab. Brain Dis. 2004, 19:229-239.
19. Ogihara H., Ogihara T., Miki M., Yasuda H., Mino M. Plasma copper and antioxidant status in Wilson's disease. Pediatr. Res. 1995, 37:219-226.
20. Mikami T., Kita K., Tomita S., Qu G.J., Tasaki Y., Ito A. Is allantoin in serum and urine a useful indicator of exercise-induced oxidative stress in humans?. Free Radic. Res. 2000, 32:235-244.
21. Young E.G., Conway C.F. On the estimation of allantoin by the Rimini-Schryver reaction. J. Biol. Chem. 1941, 142:839-853.
22. Lagendijk J., Ubbink J.B., Vermaak W.J. The determination of allantoin, a possible indicator of oxidant status, in human plasma. J. Chromatogr. Sci. 1995, 33:186-193.
23. Iwasaki Y., Inoue K., Ito R., Yoshimura Y., Saito K., Nakazawa H. Hydrophilic interaction chromatography/electrospray ionization mass spectrometry for determination of allantoin in human biological samples. Bunseki Kagaku 2005, 54:135-142.
24. Kim K.M., Henderson G.N., Frye R.F., Galloway C.D., Brown N.J., Segal M.S., Imaram W., Angerhofer A., Johnson R.J. Simultaneous determination of uric acid metabolites allantoin, 6-aminouracil, and triuret in human urine using liquid chromatography-mass spectrometry. J. Chromatogr. B 2009, 877:65-70.
25. Yan W., Byrd G.D., Ogden M.W. Quantitation of isoprostane isomers in human urine from smokers and nonsmokers by LC-MS/MS. J. Lipid Res. 2007, 48:1607-1617.